Home > Financial Ratios > LINCOLN PHARMACEUTICALS

LINCOLN PHARMACEUTICALS
EBIT Growth

    Back to All Ratios
LINCOLN PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for LINCOLN PHARMACEUTICALS
Please provide your vote to see the results

LINCOLN PHARMACEUTICALS Last 5 Year EBIT Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) -10.2120.685.2614.2023.15

What is the latest EBIT Growth ratio of LINCOLN PHARMACEUTICALS ?

The latest EBIT Growth ratio of LINCOLN PHARMACEUTICALS is -10.21 based on Mar2025 Consolidated results.
Year EBIT Growth
Mar2025-10.21
Mar202420.68
Mar20235.26
Mar202214.20
Mar202123.15

How is EBIT Growth of LINCOLN PHARMACEUTICALS Trending?

Years EBIT Growth % Change
Mar2025 -10.21
Negative
Mar2024 20.68
293.16
Mar2023 5.26
-62.96
Mar2022 14.2
-38.66
Mar2021 23.15 -

Other Financial Ratios of LINCOLN PHARMACEUTICALS


Compare EBIT Growth ratio of peers of LINCOLN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS ₹966.2 Cr -1.2% -8% -49.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹431,220.0 Cr 1.2% 2.3% -1.1% Stock Analytics
DIVIS LABORATORIES ₹168,486.0 Cr 0.9% -2.5% 8.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹127,963.0 Cr 0.5% -1.5% 12.3% Stock Analytics
CIPLA ₹121,751.0 Cr 1.1% -1.6% 4.3% Stock Analytics
DR REDDYS LABORATORIES ₹106,866.0 Cr 2.7% 2.9% 3.3% Stock Analytics


LINCOLN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS

-1.2%

-8%

-49.6%

SENSEX

0.1%

0.9%

4.5%


You may also like the below Video Courses